Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs

Project Information

CMI2T IA

Grant agreement ID: 739756

DOI

10.3030/739756

Project closed

EC signature date 28 February 2017

Start date 1 September 2017

End date 31 August 2018

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost

€ 115 625,00

EU contribution

€ 115 625,00

Coordinated by

EXOMNIS BIOTECH
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (2)

training program oncology

D1.1 Report on training program oncology (M12)

training program business aspects

D1.2 Report on training program business aspects (M12)

Publications

Peer reviewed articles (3)

Spores of <i>Clostridium</i> engineered for clinical efficacy and safety cause regression and cure of tumors <i>in vivo</i>

Author(s): John T. Heap, Jan Theys, Muhammad Ehsaan, Aleksandra M Kubiak, Ludwig Dubois, Kim Paesmans, Lieve Van Mellaert, Richard Knox, Sarah A. Kuehne, Phillipe Lambin, Nigel P. Minton
Published in: Oncotarget, Issue 5/7, 2014, ISSN 1949-2553
Publisher: Impact Journals
DOI: 10.18632/oncotarget.1761

The potential of clostridial spores as therapeutic delivery vehicles in tumour therapy

Author(s): Aleksandra M. Kubiak, Nigel P. Minton
Published in: Research in Microbiology, Issue 166/4, 2015, Page(s) 244-254, ISSN 0923-2508
Publisher: Elsevier BV
DOI: 10.1016/j.resmic.2014.12.006

Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress

Author(s): Alexandra Mowday, Christopher Guise, David Ackerley, Nigel Minton, Philippe Lambin, Ludwig Dubois, Jan Theys, Jeff Smaill, Adam Patterson
Published in: Cancers, Issue 8/7, 2016, Page(s) 63, ISSN 2072-6694
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers8070063